April 25, 2024 04:15 PM Eastern Daylight Time IRVINE, Calif.–(BUSINESS WIRE)–Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2024. Highlights and Outlook Q1 sales grew 10% on a reported and constant currency1 basis to $1.6 billion Q1 TAVR sales grew 6%; constant currency sales grew […]
Financial
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
April 25, 2024 08:31 AM Eastern Daylight Time SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, will hold a conference call on Thursday May 9, 2024 at 4:30 p.m. Eastern time to discuss its results for […]
CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine
Planning enters next phase as ABMS announces open comment period WASHINGTON, April 25, 2024 /PRNewswire/ — Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure Society of America, the Heart Rhythm Society and The Society for Cardiovascular…
CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024
PARIS–(BUSINESS WIRE)–Regulatory News: “Plan de Relance pour l’industrie – Secteurs Stratégiques” Post this CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today reports its annual results […]
Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
SUNNYVALE, Calif., April 23, 2024 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming BofA Securities 2024 Healthcare Conference.
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
ATLANTA, April 22, 2024 /PRNewswire/ — Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2024 financial results will be released on Monday, May 6, 2024 after the market closes. On that day, the…
SS Innovations International Announces Q1 2024 Company Updates
Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system FORT LAUDERDALE, Fla., April 22, 2024 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global […]
Titan Provides Update on Planned Merger with Conavi
TORONTO, Ontario, April 22, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to provide this update on its planned merger with Conavi Medical Inc. (“Conavi”) as previously announced on March 18, 2024 (the “Transaction”). As previously announced, Titan has entered into a definitive amalgamation […]
HeartCore Expands Partnership with Heart-Tech Health
NEW YORK and TOKYO, April 22, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced its Artificial Intelligence (AI) Software Development Division (“AI Division”) has engaged with Heart-Tech Health to implement AI capabilities into its Med-Tech […]
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
April 19, 2024 07:00 AM Eastern Daylight Time EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, […]



